1. Agarwal, S. K., Kester, M. B., Debelenko, L. V., Heppner, C., Emmert-Buck, M. R., Skarulis, M. C., Doppman, J. L., Kim, Y. S., Lubensky, I. A., Zhengping, Z., Green, J. S., Guru, S. C., Manickam, P., Olufemi, S-E, Liotta, L. A., Chandrasekarappa, S. C., Collins, F. S., Spiegal, A. M., Lee Burns, A. & Marx, S. J. (1997) Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet 6: 1169–1175.
2. Alexander, J. M., Biller, B. M. K., Bikkal, H., Zervas, N. T., Arnold, A. & Klibanski, A. (1990) Clinically non-functioning pituitary tumors are monoclonal in origin. J Clin Invest 86: 336–340.
3. Bassett, J. H. D., Forbes, S. A., Pannett, A. A. J., Lloyd, S. E., Christie, P. T., Wooding, C., Harding, B., Besser, G. M., Monson, J. P., Sampson, J., Wass, A. H., Wheeler, M. H. & Thakker, R. V. (1998) Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet 62: 232–244.
4. Bates, A. S., Farrell, W. E., Bicknell, E. J., Talbot, A. J., Broome, J. C., Perrett, C. W., Thakker, R. V. & Clayton, R. N. (1997) Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. J Clin Endocrinol Metab 82: 818–824.
5. Boggild, M. D., Jenkinson, S., Pistorello, M., Boscaro, M., Scanarini, M., Ternan, M. c., Perret, C. W., Thakker, R. V. & Clayton, R. N. (1994) Molecular genetic studies of sporadic pituitary tumours. J Clin Endocrinol Metab 78: 387–392.